OnKure Therapeutics logo

OnKure Therapeutics

OKUR | NASDAQ
Chart Builder DCF Calculator
$2.75
+$0.12 (+4.56%)
At close: Nov 16, 2026, 4:00 PM ET
$2.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
+4.56%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
24.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #936/1021 (Top 92%)

Key Statistics

Market Data

Market Cap $137.3M
1D Range
2.50 2.81
52W Range
2.10 5.27

Valuation (TTM)

PE -0.99
PB 0.87
EV/EBITDA 0.40

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $14.00
Loading financial charts...

Profile

OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A ...

Sector Healthcare
Industry Biotechnology
Employees 45
IPO Date Apr 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$14.00
Upside
+409.09%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.